AlzeCure Pharma AB (publ) (FRA:AC6)
Germany · Delayed Price · Currency is EUR 0.1520
0.00 (0.00%)
Last updated: Jan 28, 2026, 8:15 AM CET
AlzeCure Pharma AB Market Cap
AlzeCure Pharma AB has a market cap or net worth of €21 million as of January 30, 2026. Its market cap has increased by 120.91% in one year.
Market Cap
21.00M
Enterprise Value
15.65M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.15
Market Cap Chart
Since November 28, 2018, AlzeCure Pharma AB's market cap has decreased from 40.46M to 21.00M, a decrease of -48.10%. That is a compound annual growth rate of -8.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 21.00M | -1.22% |
| Dec 30, 2025 | 21.26M | 139.91% |
| Dec 30, 2024 | 8.86M | -48.84% |
| Dec 29, 2023 | 17.32M | -24.93% |
| Dec 30, 2022 | 23.07M | 5.16% |
| Dec 30, 2021 | 21.94M | -35.43% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Weng Fine Art AG | 29.08M |
| Biomark Diagnostics | 29.00M |
| Rubean AG | 27.29M |
| Hyrican Informationssysteme Aktiengesellschaft | 24.25M |
| ACCENTRO Real Estate AG | 21.00M |
| Petro Matad | 20.45M |
| Pearl Gold AG | 19.25M |
| tick Trading Software AG | 16.61M |